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Introduction {#sec1}
============

Beginning in December 2019, a number of cases with pneumonia of unexplained cause occurred in Wuhan, Hubei province, China. Deep sequencing from lower respiratory tract samples confirmed infection was caused by a novel coronavirus that had previously not been found in humans or animals. Subsequently, this novel coronavirus was named coronavirus disease 2019 (COVID-19) by the World Health Organization \[[@bib1]\]. COVID-19 infection causes clusters of severe respiratory illness, and its main clinical manifestations are fever, cough, shortness of breath, and myalgia or fatigue \[[@bib2],[@bib3]\]. Not only patients with symptoms but also patients in the incubation period can become the source of infection. Therefore, early diagnosis is very important.

Radiological examination, as a routine imaging tool for pneumonia diagnosis, is of great importance in the early detection and treatment of patients affected by COVID-19. Radiological examinations are relatively easy to perform and can produce fast diagnosis. Chest radiography is not sensitive for the detection of ground-glass opacity (GGO) and may demonstrate normal findings in early stage of infection. In contrast, thin-section chest CT examination plays a key role in assisting diagnosis. To date, considerable knowledge gaps remain in the chest CT imaging features of COVID-19.

In this systematic review and meta-analysis, we aim to quantitatively summarize results from published studies to date to provide a more precise estimate of detection of COVID-19 by chest CT and report on the most common imaging findings on chest CT imaging.

Materials and Methods {#sec2}
=====================

Retrieval of Studies {#sec2.1}
--------------------

We searched PubMed for studies reporting CT imaging features of COVID-19 published between December 1, 2019, and February 29, 2020. The search terms included "COVID-19" OR "2019 Novel Coronavirus" OR "2019-nCoV". In addition, we reviewed the reference lists of retrieved articles for additional articles. Two independent investigators screened titles or abstracts according to the inclusion and exclusion criteria. The meta-analysis was performed using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

Inclusion and Exclusion Criteria {#sec2.2}
--------------------------------

Titles and abstracts of the articles were screened using the following inclusion criteria to identify all eligible studies: (1) publications were original articles with full text; (2) the mean or median age of the study population was above 18 years; (3) at least one of the outcomes was chest CT imaging features of COVID-19; (4) the number of patients with corresponding imaging features was reported in the study. Studies were excluded if they (1) lacked corresponding outcome parameters or research data or (2) did not have available full texts. When there were multiple publications from the same population, only data from the most recent report or the study with the larger sample size was included.

Data Extraction {#sec2.3}
---------------

We extracted the following information from each publication: the first author's full name, study sample size, mean or median age, gender distribution, application of thin-section chest CT, results of chest CT imaging features, and number of patients with each corresponding imaging features. The recorded chest CT imaging features mainly included the following aspects: (1) patterns of the lesion (GGO, consolidation, GGO mixed consolidation, air bronchogram, interlobular septal thickening, crazy paving pattern, bronchiectasis, adjacent pleura thickening, pleural effusion, pericardial effusion, lymphadenopathy), (2) lesion distribution (bilateral lung, peripheral, central), and (3) lobe distribution and the number of lobes involved ([Fig. 1](#fig1){ref-type="fig"} ).Fig 1Baseline CT images (a-d) of a 50 year-old man admitted for symptoms of fever for 1 day: there were multiple patchy ground-glass opacities in the left upper lobe and right lower lobe (a, b). Air bronchogram and crazy paving pattern can be seen (c). Lesions are located in the peripheral area of the lung (d).

Statistical Analysis {#sec2.4}
--------------------

In this systematic review and meta-analysis, we pooled data using single-arm analysis. Because some proportions extracted from the original data were too high or too low, we transformed the data using the double arcsine method into a normal distribution. We conducted the meta-analysis using the transformed data. The pooled proportion was calculated using the result of the meta-analysis by the formula (*P* = (sin(*tp*/2))^2^). Statistical heterogeneity between studies was evaluated with Cochran's *Q* test and the *I* ^2^ statistic \[[@bib4]\]. For the *Q* statistic, *P* \< .10 was considered statistically significant for heterogeneity; for *I* ^2^, a value \>50% was considered to have severe heterogeneity. Publication bias was evaluated by constructing a funnel plot and by Egger's test \[[@bib5]\]. For Egger's test, *P* \< .10 was considered statistically significant. All statistical analyses were performed with Stata SE 12 (Stata Corp, College Station, TX) for Windows.

Results {#sec3}
=======

Characteristics of the Subjects in Selected Studies {#sec3.1}
---------------------------------------------------

Detailed search procedures are summarized in [Figure 2](#fig2){ref-type="fig"} . All of the full texts of the 41 identified articles were retrieved for detailed evaluation. Of them, 28 articles did not meet the inclusion criteria, including 6 duplicated populations, 15 case reports or case series, 3 without related data, and 4 review articles. The remaining 13 independent studies were used in the current analysis \[[@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18]\] ([Table 1](#tbl1){ref-type="table"} ). Of these studies, 10 studies reported one or more chest CT imaging signs \[[@bib6], [@bib7], [@bib8],[@bib10], [@bib11], [@bib12],[@bib14], [@bib15], [@bib16],[@bib18]\], 11 studies reported at least one kind of lung distribution \[[@bib6], [@bib7], [@bib8],[@bib10],[@bib11],[@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18]\], and 5 studies reported the lobes and total number of lobes involved \[[@bib7],[@bib9],[@bib11],[@bib15],[@bib16]\].Fig 2Flowchart on the article selection process.Table 1Characteristics of 13 reviewed studiesStudySample SizeMean or Median AgeGenderThin-section Chest CTCT AbnormalCT Imaging ManifestationsZhang et al \[[@bib18]\]935Male: 5\
Female: 4Yes7GGO, consolidation, bilateral lung\
Pleural effusionSong et al \[[@bib11]\]5149Male: 25\
Female: 26Yes51GGO, consolidation, bilateral lung, peripheral, central, pleural effusion, pericardial effusion, lymphadenopathyPan et al \[[@bib9]\]6344.9Male: 33\
Female: 30Yes63GGO, consolidationWu et al \[[@bib14]\]8044Male: 42\
Female: 38Yes76GGO, consolidation, interlobular septal thickening, crazy paving pattern, pleural effusion, pericardial effusion, lymphadenopathy, peripheral, centralBernheim et al \[[@bib7]\]12145.3Male: 61\
Female: 60Yes (22 with conventional CT)94GGO, consolidation, crazy paving pattern, pleural effusion, bronchiectasis, lymphadenopathy, peripheral, centralAi et al \[[@bib6]\].1,01451Male: 467\
Female: 547Yes888Bilateral lung, GGO, consolidation, interlobular septal thickeningShi et al \[[@bib10]\]8149.5Male: 42\
Female: 39Yes81Bilateral lung, GGO, consolidation, interlobular septal thickening, adjacent pleura thickening, air bronchogram, pleural effusion, bronchiectasis, lymphadenopathy, peripheralWang et al \[[@bib12]\]5244Male: 29\
Female: 23Yes50GGO, consolidation, interlobular septal thickeningXu et al \[[@bib16]\]5043.9Male: 29\
Female: 21Yes41GGO, consolidation, interlobular septal thickening, air bronchogram, pleural effusion, peripheral, centralZhang et al \[[@bib17]\]140 (135 with chest CT scan)57Male: 69\
Female: 71Without mention134Bilateral lungGuan et al \[[@bib8]\]1,099 (975 with chest CT scan)47Male: 637\
Female: 459Without mention840Bilateral lung, GGO, interlobular septal thickening,Wu et al \[[@bib13]\]8046.1Male: 39\
Female: 41Without mention55Bilateral lungXu et al \[[@bib15]\]9050Male: 39\
Female: 51Yes69Bilateral lung, GGO, consolidation, crazy paving pattern, interlobular septal thickening, air bronchogram, adjacent pleura thickening, pleural effusion, pericardial effusion, lymphadenopathy, peripheral[^1]

The 13 studies had 2,738 participants with 2,386 having abnormal CT imaging features. In the primary meta-analysis, we found that the pooled positive rate of the CT imaging was 89.76% (95% confidence interval \[CI\]: 84.42%-93.84%; [Fig. 3](#fig3){ref-type="fig"} ). When we excluded the studies without mention of thin-section chest CT, the result was 90.35% (95%CI: 83.68%-95.42%).Fig 3Forest plot of the studies for abnormal CT among presumed coronavirus disease 2019 infection. CI = confidence interval; ES = effect size.

Patterns of the Lesion {#sec3.2}
----------------------

In this meta-analysis, we found that typical CT imaging appearance for COVID-19 patients was GGO. The incidence of GGO was 83.31% (95% CI: 69.43%-93.35%). When we excluded the studies without mention of thin-section chest CT, the incidence of GGO was 85.49% (95% CI: 64.74%-97.89%). The incidence of GGO with mixed consolidation was 58.42% (95% CI: 48.46%-67.58%; [Fig. 4](#fig4){ref-type="fig"} ). The incidences of interlobular septal thickening, adjacent pleura thickening, and air bronchogram were also high: 48.46% (95% CI: 11.44%-86.19%), 52.46% (95% CI: 15.53%-87.54%), and 46.46% (95% CI: 17.76%-76.95%), respectively. The incidence of crazy paving pattern was 14.81% (95% CI: 6.61%-25.99%). Other atypical CT imaging findings included bronchiectasis (5.42%, 95% CI: 0.02%-19.31%), pleural effusion (5.88%, 95% CI: 3.38%-8.73%), pericardial effusion (4.55%, 95% CI: 2.09%-7.90%), and lymphadenopathy (3.38%, 95% CI: 1.00%-6.86%), respectively ([Table 2](#tbl2){ref-type="table"} ).Fig 4Forest plot of the studies for CT findings (GGO, consolidation, GGO with mixed consolidation). CI = confidence interval; ES = effect size; GGO = ground-glass opacities.Table 2CT imaging findings in the meta-analysisCT ManifestationsPooled Transformed Results (95% CI)Pooled Proportion (95% CI)[∗](#tbl2fnlowast){ref-type="table-fn"}Patterns of the lesion GGO2.3 (1.97-2.62)83.31 (69.43-93.35) Consolidation1.45 (1.22-1.68)43.97 (32.82-55.45) GGO mixed consolidation1.74 (1.54-1.93)58.42 (48.46-67.58) Air bronchogram1.5 (0.87-2.14)46.46 (17.76-76.95) Interlobular septal thickening1.54 (0.69-2.38)48.46 (11.44-86.19) Crazy paving pattern0.79 (0.52-1.07)14.81 (6.61-25.99) Bronchiectasis0.47 (0.03-0.91)5.42 (0.02-19.31) Adjacent pleura thickening1.62 (0.81-2.42)52.46 (15.53-87.54) Pleural effusion0.49 (0.37-0.6)5.88 (3.38-8.73) Pericardial effusion0.43 (0.29-0.57)4.55 (2.09-7.90) Lymphadenopathy0.37 (0.2-0.53)3.38 (1.00-6.86)Lesion distribution Bilateral lung2.17 (1.89-2.44)78.2 (65.69-88.19) Peripheral2.14 (1.72-2.55)76.95 (57.43-91.50)central0.67 (-0.07-1.4)10.81 (0.12-41.50)Lobe of lesion distribution Right upper lobe1.88 (1.67-2.1)65.22 (54.95-75.24) Right middle lobe1.67 (1.53-1.8)54.95 (47.96-61.36) Right lower lobe2.41 (2.22-2.6)87.21 (80.23-92.84) Left upper lobe1.97 (1.75-2.19)69.43 (58.91-79.02) Left lower lobe2.25 (2.12-2.39)81.41 (76.1-86.53) Bilateral upper lobes1.79 (1.6-1.97)60.87 (51.46-69.43) Bilateral lower lobes1.88 (1.69-2.07)65.22 (55.95-73.94)Number of lobes involved 10.81 (0.52-1.09)15.53 (6.61-26.88) 20.75 (0.62-0.87)13.42 (9.31-17.76) 30.67 (0.55-0.8)10.81 (7.37-15.16) 40.94 (0.76-1.12)20.51 (13.76-28.22) 51.36 (1.24-1.49)39.54 (33.76-45.96)Lobes involved ≥32 (1.808-2.192)70.81 (61.75-79.10)[^2][^3]

Lesion Distribution {#sec3.3}
-------------------

We found that most patients with COVID-19 have bilateral lung infection; the incidence was 78.2% (95% CI: 65.69%-88.19%). When we excluded the studies without mention of thin-section chest CT, bilateral lung infection was seen in 81.80% of patients (95% CI: 73.94%-88.51%). The lesions were mostly located in the peripheral area (76.95%, 95% CI: 57.43%-91.50%). Fewer lesions were located in the central (peribronchovascular) area (10.81%, 95% CI: 0.12%-41.50%; [Table 2](#tbl2){ref-type="table"}).

Lobe Distribution and Number of Lobes Involved {#sec3.4}
----------------------------------------------

COVID-19 infection can involve all lobes. In this pooled meta-analysis, we found that the right lower lobe and left lower lobe were the most commonly involved; 87.21% (95% CI: 80.23%-92.84%) and 81.41% (95% CI: 76.1%-86.53%), respectively. The incidence of bilateral lower lobes was 65.22% (95% CI: 55.95%-73.94%). The right upper lobe and left upper lobe were also commonly involved: 65.22% (95% CI: 54.95%-75.24%) and 69.43% (95% CI:58.91%-79.02%), respectively. The incidence of bilateral upper lobes was 60.87% (95% CI: 51.46-69.43%). More than half patients had right middle lobe infection (54.95%, 95% CI: 47.96%-61.36%). There were 39.54% (95% CI: 33.76%-45.96%) of patients with all lobes affected and 20.51% (95% CI: 13.76%-28.22%) patients with four lobes affected. A significant proportion of patients had three or more lobes involved (70.81%, 95% CI: 61.75%-79.10%; [Table 2](#tbl2){ref-type="table"}).

Publication Bias {#sec3.5}
----------------

*P* values for Egger's regression asymmetry test are shown in [Table 3](#tbl3){ref-type="table"} . There was a low probability of publication bias in the following subgroups: GGO mixed consolidation, air bronchogram, crazy paving pattern, pleural effusion, pericardial effusion, lymphadenopathy, peripheral, lobe of lesion distribution, and number of lobes involved. However, there was publication bias in the subgroup of abnormal GGO, consolidation, and bilateral lung involvement. Because there were only two studies in the subgroup of bronchiectasis, adjacent pleura thickening, central and bilateral upper lobes, and bilateral lower lobes, the publication bias could not be evaluated.Table 3Results of the Egger testCT Manifestations*P*Lobe of Lesion Distribution*P*Abnormal CT\<.001Right upper lobe.264GGO.001Right middle lobe.142Consolidation.007Right lower lobe.074GGO mixed consolidation.116Left upper lobe.056Air bronchogram.974Left lower lobe.064Interlobular septal thickening.025Bilateral upper lobesNACrazy paving pattern.456Bilateral lower lobesNABronchiectasisNANumber of lobes involvedAdjacent pleura thickeningNA 1.379Pleural effusion.675 2.189Pericardial effusion.942 3.219Lymphadenopathy.716 4.563Lesion distribution 5.067 Bilateral lung\<.001Lobes involved ≥3.131 Peripheral.890 CentralNA[^4]

Discussion {#sec4}
==========

Our systematic review and meta-analysis suggests that the proportion of COVID-19 detected by chest CT imaging is very high. The most typical CT imaging finding is GGO. Other common CT features in patients affected by COVID-19 included consolidation, interlobular septal thickening, adjacent pleura thickening, and air bronchograms. More than half of the patients manifested as GGO, consolidation, and adjacent pleura thickening. Imaging findings mostly involved the bilateral lungs and were located in the peripheral area of the lungs. The infection can involve all the lobes and mostly the bilateral lower lobes.

Some patients who had negative reverse-transcription polymerase chain reaction for COVID-19 at initial presentation may still show chest CT abnormalities \[[@bib19]\]. Fang et al reported that the sensitivity of first reverse-transcription polymerase chain reaction is 71%, which may be lower than that of chest CT \[[@bib20]\]. In our meta-analysis of 2,738 cases, the pooled positive rate of CT imaging was 89.76% among patients suspected to have COVID-19. Thus, chest CT plays an important role in the early diagnosis of COVID-19.

In this analysis, we found that the typical CT features of COVID-19 are GGO and lung consolidation. Some of the GGO were further developed into reticular interlobular septa thickening and crazy paving pattern, indicating that the infection leads to diffuse alveolar edema and interstitial inflammation \[[@bib21],[@bib22]\]. Several patients seemed to have pleural effusion, which may represent a poor prognostic indicator \[[@bib23]\]. Generally, viral pneumonias have similar etiological mechanisms and typical imaging findings of COVID-19. Thus, these findings also appear in other viral pneumonia such as the common cold, influenza, and other coronavirus diseases including severe acute respiratory syndrome and Middle East respiratory syndrome \[[@bib24], [@bib25], [@bib26], [@bib27], [@bib28]\].

Because COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome all belong to the family of coronaviruses, the CT imaging signs are more similar. Still, there seems to be unique imaging characteristics for COVID-19. Unilateral involvement is more common in the early stage of severe acute respiratory syndrome and Middle East respiratory syndrome \[[@bib29],[@bib30]\]. In contrast, COVID-19 infection seems to be more commonly bilateral. In this meta-analysis, most patients had bilateral lung involvement, especially the bilateral lower lobes. Overall, 70% of patients had three or more lobes involved.

Our meta-analysis has several strengths. First, the number of cases included was relatively large for 3 months of early publications, providing aggregate evidence for evaluating diagnosis of COVID-19 by chest CT. Second, the included studies were conducted in different hospitals and settings, making the results more generalizable. Third, in this analysis, we extract varieties of different imaging features, including both specific imaging features and distribution patterns in the lungs.

Our meta-analysis also has several limitations. First, a majority of the studies included did not distinguish between clinically mild, moderate, and severe patients. Furthermore, some patients may have comorbidities and chronic diseases such as diabetes and hypertension that we cannot account for. These factors may affect imaging appearances. Second, because of different CT scanners and interpreting radiologists, the reported imaging features may be variable across sites.

Credits awarded for this enduring activity are designated "SA-CME" by the American Board of Radiology (ABR) and qualify toward fulfilling requirements for Maintenance of Certification (MOC) Part II: Lifelong Learning and Self-assessment. To access the SA-CME activity visit <https://cortex.acr.org/Presenters/CaseScript/CaseView?Info=ZbeNC9w5xswRSMcPtxsmg2O%2flRc5xspupCywqlpeIok%253d>. SA-CME credit for this article expires April 24, 2020.

Take-Home Points {#sec5}
================

▪Our systematic review and meta-analysis of the early literature suggests that the proportion of suspected COVID-19 detected by chest CT imaging is high.▪Chest CT, especially thin-section chest CT, can play a central role in early diagnosis of COVID-19.▪The most common CT features in patients affected by COVID-19 included GGO, consolidation, interlobular septal thickening, adjacent pleura thickening, and air bronchograms.▪The infection most commonly involves the bilateral lungs, especially bilateral lower lobes.▪Similar imagine features are seen in other infections, and the final diagnosis of COVID-19 should still be based on reverse-transcription polymerase chain reaction.
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[^1]: GGO = ground-glass opacities.

[^2]: CI = confidence interval; GGO = ground glass opacities.

[^3]: The results are expressed as a percentage.

[^4]: GGO = ground glass opacities; NA = the publication bias could not be tested.
